RIA
CTSO icon

Regal Investment Advisors’s Cytosorbents Corp CTSO Stock Holding History

Regal Investment Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,509
Closed -$10.9K – 575
2024
Q1 		$10.9K Sell
11,509
-34,315
-75% -$33.4K ﹤0.01% 580
2023
Q4 		$50.9K Buy
45,824
+23,013
+101% +$34.2K ﹤0.01% 536
2023
Q3 		$42.9K Buy
22,811
+3,643
+19% +$10.5K ﹤0.01% 491
2023
Q2 		$68.8K Buy
19,168
+5,134
+37% +$16.2K 0.01% 499
2023
Q1 		$47.3K Buy
+14,034
New +$42.1K ﹤0.01% 506

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Regal Investment Advisors's CTSO Position: Q2 2024 in Review

Regal Investment Advisors sold out of Cytosorbents Corp (CTSO) in Q2 2024, closing a stake of 11,509 shares — an estimated $10.9K sold.

Regal Investment Advisors first reported a position in CTSO in Q1 2023 and held it in 5 quarters. The position peaked at $68.8K in Q2 2023. 50 funds tracked by Wall St. Rank hold CTSO as of Q2 2024.

  • Regal Investment Advisors reported no remaining Cytosorbents Corp position as of Q2 2024 after selling out during the quarter.
  • Regal Investment Advisors sold 11,509 Cytosorbents Corp shares in Q2 2024, an estimated $10.9K.
  • Regal Investment Advisors first reported a position in Cytosorbents Corp in Q1 2023 and held it in 5 quarters.
  • Regal Investment Advisors's Cytosorbents Corp position peaked at $68.8K in Q2 2023.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2024.

Based on Regal Investment Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.